MedPath

Study on bilvadi churna with takra in grahani

Phase 2
Conditions
Health Condition 1: K00-K95- Diseases of the digestive system
Registration Number
CTRI/2020/11/028860
Lead Sponsor
Patanjali Ayurved College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having symptom of Grahani (amavastha), i.e. Muhu baddha / drava / Durgandhita / Pichchhila Mal pravriti, Aruchi, Udara Shoola, Vistambha, Praseka, Gaurava, etc. and Irritable Bowel Syndrome are considered.

Patients irrespective of sex, religion, occupation and chronicity will be selected for the study.

Both fresh and treated cases would be taken for the study.

Exclusion Criteria

Patient aged <20 years or >50 years will be excluded.

Pregnant or lactating women will be excluded.

Only diarrhea and only constipation dominant patients will be excluded.

Patients with severe complications viz. CAD, GIT disorders, CHF, CRF will be excluded.

Patients having tuberculosis and malignancy are not supposed to be taken for study.

Intestinal Obstruction, Chornâ??s disease, Ulcerative Colitis are excluded.

Uncontrolled Diabetes Mellitus and uncontrolled Hypertension.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The assessment will be done on the basis of subjective parameters and IBS severity score, and scoring will be done before and after the treatment i.e. ï?? Positive response to treatment- decrease in IBS severity score by 50%. <br/ ><br> <br/ ><br>ï??Partial response to treatment- decrease in IBS severity score by 30-50%Timepoint: 30 days
Secondary Outcome Measures
NameTimeMethod
The assessment will be done on the basis of subjective parameters and IBS severity score, and scoring will be done before and after the treatment i.e. ï?? Positive response to treatment- decrease in IBS severity score by 50%. <br/ ><br>ï??Partial response to treatment- decrease in IBS severity score by 30-50%Timepoint: 30 days
© Copyright 2025. All Rights Reserved by MedPath